Mohammad MK - Search Results

1

Antioxidant, antihyperuricemic and xanthine oxidase inhibitory activities of Hyoscyamus reticulatus.

Mohammad MK, Almasri IM, Tawaha K, Issa A, Al-Nadaf A, Hudaib M, Alkhatib HS, Abu-Gharbieh E, Bustanji Y. Mohammad MK, et al. Pharm Biol. 2010 Dec;48(12):1376-83. doi: 10.3109/13880209.2010.483521. Epub 2010 Aug 25. Pharm Biol. 2010. PMID: 20738177 Free article.

2

Docking simulations and in vitro assay unveil potent inhibitory action of papaverine against protein tyrosine phosphatase 1B.

Bustanji Y, Taha MO, Al-Masri IM, Mohammad MK. Bustanji Y, et al. Among authors: mohammad mk. Biol Pharm Bull. 2009 Apr;32(4):640-5. doi: 10.1248/bpb.32.640. Biol Pharm Bull. 2009. PMID: 19336898 Free article.

3

Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba.

Bustanji Y, Al-Masri IM, Mohammad M, Hudaib M, Tawaha K, Tarazi H, Alkhatib HS. Bustanji Y, et al. J Enzyme Inhib Med Chem. 2011 Aug;26(4):453-9. doi: 10.3109/14756366.2010.525509. Epub 2010 Oct 28. J Enzyme Inhib Med Chem. 2011. PMID: 21028941 Free article.

4

Famotidine inhibits glycogen synthase kinase-3β: an investigation by docking simulation and experimental validation.

Mohammad M, Al-Masri IM, Issa A, Al-Ghussein MA, Fararjeh M, Alkhatib H, Taha MO, Bustanji Y. Mohammad M, et al. J Enzyme Inhib Med Chem. 2013 Aug;28(4):690-4. doi: 10.3109/14756366.2012.672413. Epub 2012 Apr 18. J Enzyme Inhib Med Chem. 2013. PMID: 22512725 Free article.

5

Modified-chitosan nanoparticles: Novel drug delivery systems improve oral bioavailability of doxorubicin.

Khdair A, Hamad I, Alkhatib H, Bustanji Y, Mohammad M, Tayem R, Aiedeh K. Khdair A, et al. Eur J Pharm Sci. 2016 Oct 10;93:38-44. doi: 10.1016/j.ejps.2016.07.012. Epub 2016 Jul 26. Eur J Pharm Sci. 2016. PMID: 27473308

6

Evaluation of immunosuppression induced by metronidazole in Balb/c mice and human peripheral blood lymphocytes.

Fararjeh M, Mohammad MK, Bustanji Y, Alkhatib H, Abdalla S. Fararjeh M, et al. Among authors: mohammad mk. Int Immunopharmacol. 2008 Feb;8(2):341-50. doi: 10.1016/j.intimp.2007.10.018. Epub 2007 Nov 20. Int Immunopharmacol. 2008. PMID: 18182250

7

Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.

Mohammad MK, Al-Masri IM, Taha MO, Al-Ghussein MA, Alkhatib HS, Najjar S, Bustanji Y. Mohammad MK, et al. Eur J Pharmacol. 2008 Apr 14;584(1):185-91. doi: 10.1016/j.ejphar.2008.01.019. Epub 2008 Jan 30. Eur J Pharmacol. 2008. PMID: 18295757

8

Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.

Bustanji Y, Taha MO, Almasri IM, Al-Ghussein MA, Mohammad MK, Alkhatib HS. Bustanji Y, et al. Among authors: mohammad mk. J Enzyme Inhib Med Chem. 2009 Jun;24(3):771-8. doi: 10.1080/14756360802364377. J Enzyme Inhib Med Chem. 2009. PMID: 18720192 Free article.

9

Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.

Al-Masri IM, Mohammad MK, Taha MO. Al-Masri IM, et al. Among authors: mohammad mk. ChemMedChem. 2008 Nov;3(11):1763-79. doi: 10.1002/cmdc.200800213. ChemMedChem. 2008. PMID: 18989859

10

Xanthine oxidase inhibitory activity of the methanolic extracts of selected Jordanian medicinal plants.

Hudaib MM, Tawaha KA, Mohammad MK, Assaf AM, Issa AY, Alali FQ, Aburjai TA, Bustanji YK. Hudaib MM, et al. Among authors: mohammad mk. Pharmacogn Mag. 2011 Oct;7(28):320-4. doi: 10.4103/0973-1296.90413. Pharmacogn Mag. 2011. PMID: 22262935 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters